Shilpa Kumari

@mrsptu.ac.in

Assistant Professor/DoPST
Maharaja Ranjit Singh Punjab Technical University

Shilpa Kumari


               Download Compact PDF  
https://researchid.co/shil1pa

EDUCATION

M.Pharmacy (Pharmacology) Batch 2018-2020, MRSPTU, PB, INDIA

RESEARCH INTERESTS

Neuroscience, Alzhiemer's disease
15

Scopus Publications

87

Scholar Citations

6

Scholar h-index

2

Scholar i10-index

Scopus Publications

RECENT SCHOLAR PUBLICATIONS

  • Molecular Basis for the Protective Effect of Dietary Components Against Alzheimer’s Disease
    K Bagri, S Kumari, M Bishnoi, R Deshmukh
    Diet and Alzheimer's Disease: Let Food be Our Medicine, 37-57 , 2025
    2025
    Citations: 1
  • Tangles and Plaques: A deep dive into the pathological hallmarks of Alzheimer’s disease
    S Kumari, K Bagri, R Deshmukh
    Neuroscience , 2025
    2025
    Citations: 6
  • Parkinson’s disease: genetics and neuroinflammatory insights
    I Chandel, S Kumari, K Bagri, A Bhatia, R Deshmukh
    Inflammopharmacology 33 (9), 4997-5009 , 2025
    2025
    Citations: 3
  • Traumatic Brian Injury (TBI) unraveled: molecular disruptions and therapeutic avenues: N. Kumari et al.
    N Kumari, K Bagri, S Kumari, R Deshmukh
    Inflammopharmacology 33 (8), 4323-4334 , 2025
    2025
    Citations: 8
  • Ceramide: a central regulator in Alzheimer’s disease pathogenesis: Priyanka et al.
    P Choudhary, S Kumari, K Bagri, R Deshmukh
    Inflammopharmacology 33 (4), 1775-1783 , 2025
    2025
    Citations: 7
  • Connecting dots: Preclinical foundations to clinical realities of PDE4 inhibitors in Alzheimer's disease
    S Kumari, K Bagri, R Deshmukh
    Inflammopharmacology 33 (2), 593-603 , 2025
    2025
    Citations: 6
  • Neuroprotective potential of quetiapine against streptozotocin‐induced sporadic Alzheimer’s disease
    S Kumari, P Attri, RR Deshmukh
    Alzheimer's & Dementia 20, e088739 , 2024
    2024
  • Preclinical and Clinical Aspects of I/R Injuries
    S Kumari, R Deshmukh, TG Singh
    Ischemic Injury, 37-55 , 2024
    2024
  • Role of GSK-3 Inhibition in Modulating the Pathology of Stroke
    R Sharma, S Kumari, S Kapoor, R Deshmukh, TG Singh
    Ischemic Injury, 453-470 , 2024
    2024
  • Ischemic Injury: A Molecular Insight
    TG Singh, H Khan
    CRC Press , 2024
    2024
  • Molecular Aspects of Ischemic Reperfusion Injury
    S Kumari, C Sharma, R Deshmukh, TG Singh
    Ischemic Injury, 57-78 , 2024
    2024
  • Role of the renin-angiotensin-aldosterone system (RAAS) in amelioration of stroke pathophysiology
    R Sandhu, S Kumari, S Thakur, R Deshmukh, TG Singh
    Ischemic Injury, 217-232 , 2024
    2024
    Citations: 2
  • Implication of mitogen-activated protein kinase (MAPK) in cerebral stroke
    S Kumari, P Attri, R Deshmukh, TG Singh
    Ischemic Injury, 411-425 , 2024
    2024
    Citations: 1
  • Neuroprotective effect of Tropisetron in Streptozotocin induced animal model of Alzheimer’s disease
    S Kumari, RR Deshmukh, R Sharma
    Alzheimer's & Dementia 19, e077618 , 2023
    2023
  • Dementia: A journey from cause to cure
    S Kumari, K Bagri, R Deshmukh
    Nanomedicine-Based Approaches for the Treatment of Dementia, 37-56 , 2023
    2023
    Citations: 6
  • Fingolimod (FTY720) offers neuroprotection against AlCl 3 induced Experimental Dementia in Rats
    S Kumari, M Agrawal, RR Deshmukh
    Alzheimer's & Dementia 18, e067689 , 2022
    2022
    Citations: 3
  • Dipeptidyl peptidase 4 (DPP4) inhibitors stride up the management of Parkinson's disease
    S Kumari, R Deshmukh
    European Journal of Pharmacology, 175426 , 2022
    2022
    Citations: 15
  • Nanomedicine-based Approaches for the Treatment of Dementia
    U Gupta, P Kesharwani
    Academic Press , 2022
    2022
    Citations: 6
  • β-Lactam antibiotics to tame down molecular pathways of Alzheimer's disease
    S Kumari, R Deshmukh
    European Journal of Pharmacology 895, 173877 , 2021
    2021
    Citations: 23
  • Neuroprotective Potential of Ceftriaxone Alone And In Combination With Minocycline In Experimental Sporadic Alzheimer's Disease
    S Kumari
    MRSPTU, Bathinda , 2020
    2020

MOST CITED SCHOLAR PUBLICATIONS

  • β-Lactam antibiotics to tame down molecular pathways of Alzheimer's disease
    S Kumari, R Deshmukh
    European Journal of Pharmacology 895, 173877 , 2021
    2021
    Citations: 23
  • Dipeptidyl peptidase 4 (DPP4) inhibitors stride up the management of Parkinson's disease
    S Kumari, R Deshmukh
    European Journal of Pharmacology, 175426 , 2022
    2022
    Citations: 15
  • Traumatic Brian Injury (TBI) unraveled: molecular disruptions and therapeutic avenues: N. Kumari et al.
    N Kumari, K Bagri, S Kumari, R Deshmukh
    Inflammopharmacology 33 (8), 4323-4334 , 2025
    2025
    Citations: 8
  • Ceramide: a central regulator in Alzheimer’s disease pathogenesis: Priyanka et al.
    P Choudhary, S Kumari, K Bagri, R Deshmukh
    Inflammopharmacology 33 (4), 1775-1783 , 2025
    2025
    Citations: 7
  • Tangles and Plaques: A deep dive into the pathological hallmarks of Alzheimer’s disease
    S Kumari, K Bagri, R Deshmukh
    Neuroscience , 2025
    2025
    Citations: 6
  • Connecting dots: Preclinical foundations to clinical realities of PDE4 inhibitors in Alzheimer's disease
    S Kumari, K Bagri, R Deshmukh
    Inflammopharmacology 33 (2), 593-603 , 2025
    2025
    Citations: 6
  • Dementia: A journey from cause to cure
    S Kumari, K Bagri, R Deshmukh
    Nanomedicine-Based Approaches for the Treatment of Dementia, 37-56 , 2023
    2023
    Citations: 6
  • Nanomedicine-based Approaches for the Treatment of Dementia
    U Gupta, P Kesharwani
    Academic Press , 2022
    2022
    Citations: 6
  • Parkinson’s disease: genetics and neuroinflammatory insights
    I Chandel, S Kumari, K Bagri, A Bhatia, R Deshmukh
    Inflammopharmacology 33 (9), 4997-5009 , 2025
    2025
    Citations: 3
  • Fingolimod (FTY720) offers neuroprotection against AlCl 3 induced Experimental Dementia in Rats
    S Kumari, M Agrawal, RR Deshmukh
    Alzheimer's & Dementia 18, e067689 , 2022
    2022
    Citations: 3
  • Role of the renin-angiotensin-aldosterone system (RAAS) in amelioration of stroke pathophysiology
    R Sandhu, S Kumari, S Thakur, R Deshmukh, TG Singh
    Ischemic Injury, 217-232 , 2024
    2024
    Citations: 2
  • Molecular Basis for the Protective Effect of Dietary Components Against Alzheimer’s Disease
    K Bagri, S Kumari, M Bishnoi, R Deshmukh
    Diet and Alzheimer's Disease: Let Food be Our Medicine, 37-57 , 2025
    2025
    Citations: 1
  • Implication of mitogen-activated protein kinase (MAPK) in cerebral stroke
    S Kumari, P Attri, R Deshmukh, TG Singh
    Ischemic Injury, 411-425 , 2024
    2024
    Citations: 1
  • Neuroprotective potential of quetiapine against streptozotocin‐induced sporadic Alzheimer’s disease
    S Kumari, P Attri, RR Deshmukh
    Alzheimer's & Dementia 20, e088739 , 2024
    2024
  • Preclinical and Clinical Aspects of I/R Injuries
    S Kumari, R Deshmukh, TG Singh
    Ischemic Injury, 37-55 , 2024
    2024
  • Role of GSK-3 Inhibition in Modulating the Pathology of Stroke
    R Sharma, S Kumari, S Kapoor, R Deshmukh, TG Singh
    Ischemic Injury, 453-470 , 2024
    2024
  • Ischemic Injury: A Molecular Insight
    TG Singh, H Khan
    CRC Press , 2024
    2024
  • Molecular Aspects of Ischemic Reperfusion Injury
    S Kumari, C Sharma, R Deshmukh, TG Singh
    Ischemic Injury, 57-78 , 2024
    2024
  • Neuroprotective effect of Tropisetron in Streptozotocin induced animal model of Alzheimer’s disease
    S Kumari, RR Deshmukh, R Sharma
    Alzheimer's & Dementia 19, e077618 , 2023
    2023
  • Neuroprotective Potential of Ceftriaxone Alone And In Combination With Minocycline In Experimental Sporadic Alzheimer's Disease
    S Kumari
    MRSPTU, Bathinda , 2020
    2020